Login

Brickability Group PLC: Leading Construction Materials Distributor | Alan Simpson - CEO of Brickability Gr 00:10:00

Share On Facebook Share On Twitter

Alan Simpson is the CEO of Brickability Gr

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Guillaume Paoli on Resilience in the Automobile Market: Insights from Aramis Group | Guillaume Paoli, CEO, Aramis Group.
00:10:00
CEO Mike Gianoni Reflects on 2019 at BBCON | Mike Gianoni, CEO, Blackbaud Inc.
00:10:00
June Market Volatility: Global Recession Fears and Strategic Fund Adjustments
00:10:00
Chairman Dinesh Kumar Khara on Asset Quality, Credit Growth, and Strategic Focus | Dinesh Kumar Khara, Chairman , State Bank of India.
00:10:00
Toni Townes-Whitley, CEO of Science Applications International Corp. (SAIC), discusses her company's strategy and initiatives on 'Squawk Box'.
00:10:00
Argenica Therapeutics Achieves Major Milestone in Phase 2 Stroke Drug Trial | Liz Dallimore, CEO , Argenica Therapeutics Ltd.
00:10:00
Prospecting Gold and Copper: Challenger Exploration's Path Forward
00:10:00
We are devoted to our clients and it's reflected by our tenure, scale, and recognition as the industry's fastest growing target date suite. Our dedication to clients is matched by our commitment to our community. flexPATH Strategies is pleased to fundrais
00:10:00
Alteryx CEO on the use of analytics automation for census data | Mark Anderson, CEO, Alteryx IncAYX:NYQ
00:10:00
CEO Jeff Guldner Discusses Clean Energy Transition and Leadership Amidst Crisis | Jeffrey B. Guldner, CEO , Pinnacle West Capital Corporation.
00:10:00
Uncovering both long and short opportunities through in-depth original research|Mr. Obus, Partner,Wynnefield Capital Inc.
00:10:00
Investing in Education: Understanding the 529 Plan with Smitha Walling of Vanguard | Smitha Walling - Head of Education Savings, Vanguard

© 2026 Nehu